Leadless Pacemaker Implantation After Tricuspid Valve Replacement

三尖瓣置换术后植入无导线起搏器

阅读:1

Abstract

BACKGROUND: Tricuspid valve disease is gaining clinical significance, with transcatheter tricuspid valve replacement (TTVR) emerging as a viable alternative to surgery. Atrioventricular block is a known postprocedural complication. To avoid interference with the valve prosthesis, leadless pacemakers (LPMs) are preferred over transvenous systems. CASE SUMMARY: An 87-year-old woman developed symptomatic bradycardic atrial fibrillation 3 months after TTVR with an Evoque prosthesis (Edwards Lifesciences). Given her age and comorbidities, an AVEIR VR (Abbott Medical) LPM was implanted via right jugular vein approach, chosen because of the orientation of the prosthesis. During the first attempt, the pacemaker's helix became entangled in the valve frame despite the use of a protective sleeve. The device was safely retrieved, and a second attempt was successful. Postimplantation imaging confirmed preserved valve function. DISCUSSION: This case underscores the importance of individualized procedural planning for LPM implantation after TTVR. The jugular approach, combined with tailored fluoroscopic angulation, can improve catheter control and reduce the risk of prosthesis interaction. TAKE-HOME MESSAGE: LPM implantation after TTVR is feasible. Optimal access selection, imaging strategy, and sheath handling are essential to minimize complications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。